Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on AMEX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| MAG | MAG Silver Corp | 2018 | 10.680000 | 22.9630 | CAD | 7 |
| RNN | Rexahn Pharmaceuticals Inc | 2018 | 2.160000 | 13.0000 | USD | 1 |
| AST | Asterias Biotherapeutics Inc | 2018 | 2.200000 | 12.0000 | USD | 1 |
| GDP | Goodrich Petroleum Corp | 2018 | 11.729900 | 20.0000 | USD | 2 |
| OCX | OncoCyte Corp | 2018 | 4.050000 | 12.0000 | USD | 1 |
| REI | Ring Energy Inc | 2018 | 13.620000 | 21.0000 | USD | 2 |
| CQH | Cheniere Energy Partners LP Holdings LLC | 2018 | 28.420000 | 35.0000 | USD | 1 |
| ACU | Acme United Corp | 2018 | 23.840000 | 29.5000 | USD | 2 |
| PTN | Palatin Technologies Inc | 2018 | 0.990000 | 6.0000 | USD | 1 |
| MTNB | Matinas BioPharma Holdings Inc | 2018 | 1.150000 | 6.0000 | USD | 1 |
| APHB | Ampliphi Biosciences Corp | 2018 | 1.210000 | 6.0000 | USD | 1 |
| CQP | Cheniere Energy Partners LP | 2018 | 30.890000 | 35.5000 | USD | 2 |
| ALO | Alio Gold Inc | 2018 | 3.230000 | 7.7818 | CAD | 11 |
| DLA | Delta Apparel Inc | 2018 | 19.520000 | 24.0000 | USD | 1 |
| UUUU | Energy Fuels Inc | 2018 | 1.570000 | 5.9739 | CAD | 1 |
| NG | Novagold Resources Inc | 2018 | 3.720000 | 8.0000 | CAD | 1 |
| USAS | Americas Silver Corp | 2018 | 4.080000 | 8.2750 | CAD | 2 |
| JOB | GEE Group Inc | 2018 | 3.040000 | 7.0000 | USD | 1 |
| BRG | Bluerock Residential Growth REIT Inc | 2018 | 8.040000 | 12.0000 | USD | 2 |
| ATNM | Actinium Pharmaceuticals Inc | 2018 | 0.712000 | 4.5000 | USD | 2 |
| PLYM | Plymouth Industrial REIT Inc | 2018 | 17.240000 | 21.0000 | USD | 1 |
| PARR | Par Pacific Holdings Inc | 2018 | 18.280000 | 22.0000 | USD | 1 |
| VISI | Volt Information Sciences Inc | 2018 | 4.400000 | 8.0000 | USD | 1 |
| LLEX | Lilis Energy Inc | 2018 | 4.420000 | 8.0000 | USD | 1 |
| CRMD | Cormedix Inc | 2018 | 0.468800 | 4.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
RNN:ASE Rexahn Pharmaceuticals
http://www.rexahn.com
Rexahn Pharmaceuticals has 20 employees and is headquartered in United States.
Rexahn Pharmaceuticals Inc is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of treatments for cancer.
AST:ASE Asterias Biotherapeutics
http://www.asteriasbiotherapeutics.com
Asterias Biotherapeutics has 55 employees and is headquartered in United States.
Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.